首页> 外文期刊>Thoracic cancer. >Cx43 and AKAP95 regulate G1 /S conversion by competitively binding to cyclin E1 / E2 in lung cancer cells
【24h】

Cx43 and AKAP95 regulate G1 /S conversion by competitively binding to cyclin E1 / E2 in lung cancer cells

机译:CX43和AKAP95通过在肺癌细胞中竞争地结合细胞周期蛋白E1 / E2来调节G1 / s转化率

获取原文
           

摘要

BACKGROUND:This study aimed to overexpress or silence connexin 43 (Cx43) and A-kinase anchoring protein 95 (AKAP95) in human A549 cells to explore their effects on cyclins and on G1/S conversion when the interrelationship of Cx43, AKAP95, and cyclin E1/E2 changes.METHODS:The study mainly used Western blot analysis and Co-immuno precipitation to detect the target protein in Cx43/AKAP95 over expressed human A549 cells, and the relationship of proteins Cx43, AKAP95 and Cyclin E during G1-S phase was explored with qualitative and quantitative analysis.RESULTS:The overexpression of Cx43 inhibited the expression of cyclin D1 and E1 by accelerating their degradation and reduced the Cdk2 activity that blocked the DNA transcription activity. However, the overexpression of AKAP95 increased the expression of cyclin D1 and E1 and inhibited their degradation, and enhanced the Cdk2 activity that promoted the DNA transcription activity. Cx43 and AKAP95 competitively bound to cyclin E1/E2, and the competitive binding affected the Cdk2 activity, Rb phosphorylation, DNA transcription activity, and G1/S conversion.CONCLUSIONS:This study showed that the expression of ERK1/2, PKA, and PKB increased when BEAS-2B cells were treated with PDGF-BB, suggesting that ERK1/2, PKA, and PKB might be involved in the binding of AKAP95 with cyclin E, or the separation of AKAP95 from Cx43 from cyclin E1/E2. The specific mechanism underlying this process still needs further exploration.? 2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
机译:背景:本研究旨在过表达或沉默的Connexin 43(CX43)和人A549细胞中的A-激酶锚定蛋白95(AKAP95),以探讨CX43,AKAP95和Cyclin的相互关系时对细胞周期司和G1 / S转化的影响E1 / E2变化。方法:该研究主要使用Western印迹分析和共免疫沉淀,以检测CX43 / AKAP95中的靶蛋白,对表达的人A549细胞,以及G1-S期间蛋白CX43,AKAP95和Cyclin e的关系探索了定性和定量分析。结果:CX43的过表达通过加速其降解并降低阻断DNA转录活性的CDK2活性来抑制细胞周期蛋白D1和E1的表达。然而,AKAP95的过表达增加了细胞周期蛋白D1和E1的表达,并抑制了它们的降解,并增强了促进DNA转录活性的CDK2活性。 CX43和AKAP95竞争性地结合细胞周期蛋白E1 / E2,竞争结合影响了CDK2活性,RB磷酸化,DNA转录活性和G1 / S转化。结论:该研究表明ERK1 / 2,PKA和PKB的表达当用PDGF-BB处理BEA-2B细胞时增加,表明ERK1 / 2,PKA和PKB可能参与AKAP95与细胞周期蛋白E的结合,或者从Cyclin E1 / E2与CX43分离Akap95。此过程的具体机制仍需要进一步的探索。 2020作者。中国肺部肿瘤集团和约翰瓦里和儿子澳大利亚发表的胸癌

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号